107 related articles for article (PubMed ID: 7924332)
1. Mixed lymphocyte culture responses in rabbits undergoing corneal grafting and topical cyclosporine treatment.
Maske R; Hill JC; Horak S
Cornea; 1994 Jul; 13(4):324-30. PubMed ID: 7924332
[TBL] [Abstract][Full Text] [Related]
2. Suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns.
Rehany U; Waisman M
Cornea; 1994 Sep; 13(5):447-53. PubMed ID: 7995070
[TBL] [Abstract][Full Text] [Related]
3. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
Mahlberg K; Uusitalo RJ; Oksala O
Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
[TBL] [Abstract][Full Text] [Related]
5. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
[TBL] [Abstract][Full Text] [Related]
7. Preliminary findings in corneal allograft rejection in patients with keratoconus.
Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
[TBL] [Abstract][Full Text] [Related]
8. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
[TBL] [Abstract][Full Text] [Related]
10. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
[TBL] [Abstract][Full Text] [Related]
11. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
12. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy.
Hill JC
Ophthalmology; 1994 Jan; 101(1):128-33. PubMed ID: 8302545
[TBL] [Abstract][Full Text] [Related]
13. Topical FK-506 prevents experimental corneal allograft rejection.
Mills RA; Jones DB; Winkler CR; Wallace GW; Wilhelmus KR
Cornea; 1995 Mar; 14(2):157-60. PubMed ID: 7538061
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer.
Xie L; Shi W; Wang Z; Bei J; Wang S
Cornea; 2001 Oct; 20(7):748-52. PubMed ID: 11588429
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
Shi W; Chen M; Xie L
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
[TBL] [Abstract][Full Text] [Related]
16. Long-term study of vascularized free-draining intraperitoneal pancreatic segmental allografts in beagle dogs.
Kyriakides GK; Rabinovitch A; Mintz D; Olson L; Rapaport FT; Miller J
J Clin Invest; 1981 Jan; 67(1):292-303. PubMed ID: 6450223
[TBL] [Abstract][Full Text] [Related]
17. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
[TBL] [Abstract][Full Text] [Related]
18. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
Zhang W; Pan Z; Zhai C
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
